nomifensine has been researched along with Chorea Disorders in 2 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HY | 1 |
| Nakayama, J | 1 |
| Xu, Y | 1 |
| Fan, X | 1 |
| Karouani, M | 1 |
| Shen, Y | 1 |
| Pothos, EN | 1 |
| Hess, EJ | 1 |
| Fu, YH | 1 |
| Edwards, RH | 1 |
| Ptácek, LJ | 1 |
| Sandyk, R | 1 |
2 other studies available for nomifensine and Chorea Disorders
| Article | Year |
|---|---|
Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia.
Topics: Amino Acid Sequence; Animals; Chorea; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; HEK293 | 2012 |
Nomifensine-induced orofacial dyskinesia and Sydenham's chorea.
Topics: Chorea; Dyskinesia, Drug-Induced; Facial Muscles; Female; Humans; Middle Aged; Mouth; Nomifensine; S | 1987 |